A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy and safety in Japanese adult
subjects with Intra-abdominal/Pelvic infections receiving Metronidazole IV 1,500-2,000 mg/day
in combination with ceftriaxone sodium.